call North America: +1 617 821 0595 | EU: +32 471 808710 | India: +91 73867 22272

Speak to Our Expert

Oligonucleotide Synthesis Services LP Oligonucleotide Synthesis Services LP

Oligonucleotide Synthesis Services

Speak to our Expert

By submittng this form you accept the Privacy Policy and Terms of Use of this website.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

About Aurigene Pharmaceutical Services

Aurigene Pharmaceutical Services Limited (APSL) is an integrated partner for global pharma companies. It covers the entire value chain for new therapeutics, from drug discovery, clinical research, and development to manufacturing APIs and formulation at commercial scales. It has development laboratories from discovery to clinical phase III for New Chemical and Biological Entities (NCEs/NBEs) and cGMP manufacturing facilities in the UK, Mexico, USA, and India. The technology platforms include cytotoxic APIs, carbohydrates, steroids, PEG derivatives, prostaglandins, peptides, and oligonucleotides. Large molecule discovery services include ADC, MAB, mRNA, CART-T as well as development services in MAB and protein therapeutics.

Oligonucleotide Synthesis

At our state-of-the-art drug discovery facility for oligonucleotide synthesis, our team accelerates your early drug discovery. With years of experience in small molecules, we can design molecules, overcoming bioavailability issues, and devising a fast-forward approach for your oligo targets across therapeutic areas such as oncology, inflammation, and anti-bacterial, etc.

Oligonucleotide Synthesis

Why Aurigene Pharmaceutical Services for Oligonucleotide Synthesis Services

  • Capabilities to perform purification, characterization, biological evaluation and conjugation
  • In house custom synthesis of phosphoramidites
  • Complex conjugation using click chemistry, Amine-acid, Thiol-maleimide, intramolecular cyclization and SNAr of Oligo amines with Floro
  • Ion exchange and reverse phase HPLC
  • Integrated Discovery (Synthesis + biological validation)

Aurigene Advantage

  • 20+ years of experience in accelerating drug innovation

  • Highly experienced scientific and scale-up teams

  • Global accreditations

  • Dedicated manufacturing setup withpilot and commercial scale capability

  • Industry-leading expertise in discovery and CMC services

  • Strong and sustainable Operations

  • Advocates of long-term partnerships

  • Flexible services and business model

Virtual Tour


© 2023 Aurigene Pharmaceutical Services Ltd. | All rights reserved.


You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.